WT1 and pancreatic neoplasm: This study aimed to reveal the CD8+ T cell response to WT1 and individual neoantigens from memory T cell subsets in the immune suppressive environment using an MPE model sampled from a patient with pancreatic cancer who received the dendritic cell vaccination targeting the WT1 antigen.